Dyrax-Q Tab

Manufacturer: Cho-A Pharm.Co.,Ltd.
Effective date: 2023-03-15
Label type: HUMAN OTC DRUG LABEL
Version: 8
Source: legacy-cache
Hydrated at: 2026-08-01 21:34:36

Label at a glance#

ProductDyrax-Q Tab

Active ingredientBISACODYL, DOCUSATE SODIUM

Label structure8 sections

Indications and uses

For temporary relief of occasional constipation and irregularity

Dosage and administration

adults and children 15 years and older 2 tablets at once per day (at bedtime) children 12 – 14 years 1 1/3 tablet at once per day (at bedtime) children 8 – 11 years 1 tablet at once per day (at bedtime)

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Bisacodyl 5 mg

Docusate Sodium 16.75 mg

Purpose

OTC - PURPOSE SECTION

Laxative

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact Poison Control Center right away.

Uses

INDICATIONS & USAGE SECTION

For temporary relief of occasional constipation and irregularity

Warnings

WARNINGS SECTION

For external use only

Ask a doctor before use if you have

stomach pain, nausea or vomiting,
a sudden change in bowel habits that lasts more than 2 weeks

If Pregnant or breast-feeding, ask a health professional before use.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 15 years and older

2 tablets at once per day (at bedtime)

children 12 – 14 years

1 1/3 tablet at once per day (at bedtime)

children 8 – 11 years

1 tablet at once per day (at bedtime)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Corn Starch, Colloidal Silicon Dioxide, Ethanol, Hydroxypropylcellulose, Lactose Hydrate, Magnesium Stearate, Sodium Lauryl Sulfate, OPADRY OY-C-7000A WHITE, ACRYL-EZE White, Food Yellow No.203, Food Blue No.1, Purified Water, Ursodesoxycholic Acid.

Dyrax-Q Tab

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dyrax-Q Tab

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
58354-117-02	2024-01-30	C162847	48780-1	1030e365-1413-111a-e063-dadaa90a10e2	Dyrax-Q Tab

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

Dyrax-Q Tab
Bisacodyl, Docusate Sodium
BISACODYL
DEACETYLBISACODYL
MAGNESIUM STEARATE
SODIUM LAURYL SULFATE
DOCUSATE SODIUM
DOCUSATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
58354-117	58354-117-01, 58354-117-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BISACODYL	10X0709Y6I	ACTIB
MAGNESIUM STEARATE	70097M6I30	IACT
SODIUM LAURYL SULFATE	368GB5141J	IACT
DOCUSATE SODIUM	F05Q2T2JA0	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
1b8c00ca-e8d7-4b4b-e063-6294a90abeef			95b98359-5002-b8f4-e053-2995a90a8961	2024-06-23	Warnings	Exact identifier spl set id: 95b98359-5002-b8f4-e053-2995a90a8961

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.